Bioteque : The announcement of at least one-third of the company’s Directors altered during the Director re-election in the company’s general shareholders’meeting in 2022.

Close

Today's Information

Provided by: BIOTEQUE CORPORATION
SEQ_NO	2	Date of announcement	2022/06/16	Time of announcement	14:15:21
Subject	The announcement of at least one-third of the company's Directors altered during the Director re-election in the company's general shareholders'meeting in 2022.
Date of events	2022/06/15	To which item it meets	paragraph 6
Statement	1.Date of occurrence of the change:2022/06/15 2.Elected or changed position (Please enter institutional director, institutional supervisor, independent director, natural-person director or natural-person supervisor):institutional director, independent director,natural-person director 3.Title and name of the previous position holder: director-Zong-Li Tsai，Chairman of the Company director-Ming-Zhong Li，General Manager of the Company director-Yi-Xun Li，Vice President of the Company director-Zong Yu Investment Co., Ltd.-Representative:Jing-Yi Tsai ，Vice President of the Company director-Pang-Yen Zhang，Chairman of Pulibang Biotech Consulting Company Limited director-Jin-Long Lin，Senior Vice Presidentof the Company independent director-Zheng-Xiong Xu，Chairman of Yuantong International Management Consulting Co., Ltd. independent director-Bin-Xi Lin，Attending Physician, Division of Nephrology, Shin Kong Wu Ho-Su Memorial Hospital director-Yi-Zhong Huang，Chief Financial Officer of the Company 4.Resume of the previous position holder: director-Zong-Li Tsai，Chairman of the Company director-Ming-Zhong Li，General Manager of the Company director-Yi-Xun Li，Vice President of the Company director-Zong Yu Investment Co., Ltd.-Representative:Jing-Yi Tsai Vice President of the Company director-Pang-Yen Zhang，Chairman of Pulibang Biotech Consulting Company Limited director-Jin-Long Lin，Senior Vice Presidentof the Company independent director-Zheng-Xiong Xu，Chairman of Yuantong International Management Consulting Co., Ltd. independent director-Bin-Xi Lin，Attending Physician, Division of Nephrology, Shin Kong Wu Ho-Su Memorial Hospital director-Yi-Zhong Huang，Chief Financial Officer of the Company 5.Title and name of the new position holder: institutional director-Ming Sheng Co., Ltd. Representative:Ming-Zhong Li natural-person director-Tang-Lung Hsu institutional director-Yide Co., Ltd. Representative:Hsu-Yuan Li institutional director-Yisheng Co., Ltd. Representative:Wen-Chung Yeh institutional director-Ming Sheng Co., Representative:Yi-Xun Li institutional director-Zong Yu Investment Co., Ltd.- Representative:Jing-Yi Tsai institutional director-Zong Yu Investment Co., Ltd.- Representative:Xing Wang natural-person director-Yao-Ren Ho natural-person director-Ming Yeh.Cheng independent director-Ren-Fang Li independent director-Bin-Xi Lin independent director-Teng-Yao Hsiao 6.Resume of the new position holder: institutional director-Ming Sheng Co., Ltd. Representative:Ming-Zhong Li，Chairman of the Company natural-person director-Tang-Lung Hsu，Catcher Technology Co., Ltd. - Vice President institutional director-Yide Co., Ltd. Representative:Hsu-Yuan Li，Catcher Technology Co., Ltd. - Vice President institutional director-Yisheng Co., Ltd. Representative:Wen-Chung Yeh， Catcher Technology Co., Ltd.-Chairman's special assistant institutional director-Ming Sheng Co.,Representative:Yi-Xun Li， Vice Presidentof the Company institutional director-Zong Yu Investment Co., Ltd.- Representative:Jing-Yi Tsai Vice Presidentof the Company institutional director-Zong Yu Investment Co., Ltd.- Representative:Xing Wang- Superintendent of Jixing/Dingxiang Clinic natural-person director-Yao-Ren Ho， Ti Mao Co., Ltd.General Manager natural-person director-Ming Yeh.Cheng，Phoebes Inc.- Editor in chief independent director-Ren-Fang Li，BenQ Medical Technology Corporation -Independent Director independent director-Bin-Xi Lin，Attending Physician, Division of Nephrology, Shin Kong Wu Ho-Su Memorial Hospital independent director-Teng-Yao Hsiao， Yun Cheng CPA Firm- Accountant 7.Circumstances of change (Please enter "resignation", "dismissal", "term expired", "death" or "new appointment"):term expired 8.Reason for the change:Term expired and full re-election. 9.Number of shares held by the new position holder when elected: institutional director-Ming Sheng Co., Ltd.1,917,000 shares Representative:Ming-Zhong Li:725,346 shares natural-person director-Tang-Lung Hsu:0 shares institutional director-Yide Co., Ltd.2,233,000 shares Representative:Hsu-Yuan Li:0 shares institutional director-Yisheng Co., Ltd.2,589,000 shares Representative:Wen-Chung Yeh:0 shares institutional director-Ming Sheng Co.,Ltd.1,917,000 shares Representative:Yi-Xun Li:732,245 shares institutional director-Zong Yu Investment Co., Ltd.-1,611,752 shares Representative-Jing-Yi Tsai:178,572 shares institutional director-Zong Yu Investment Co., Ltd.-1,611,752 shares Representative-Xing Wang:44,000 shares natural-person director-Yao-Ren Ho:100,000 shares natural-person director-Ming Yeh.Cheng:88,000 shares independent director-Ren-Fang Li:0 shares independent director-Bin-Xi Lin:0 shares independent director-Teng-Yao Hsiao:0 shares 10.Original term (from __________ to __________): from 2019/06/18 to 2022/06/17 11.Effective date of the new appointment:2022/06/15~2025/06/14 12.Turnover rate of directors of the same term: Term expired and full re-election. 13.Turnover rate of independent directors of the same term: Term expired and full re-election. 14.Turnover rate of supervisors of the same term: Term expired and full re-election. 15.Change in one-third or more of directors (Please enter "Yes" or "No"):"Yes" 16.Any other matters that need to be specified:None